Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: DocMorris AG

Market Cap 41Cr 52Cr 45Cr 39Cr 73Cr 4.91TCr 74Cr 489.37Cr 190.52Cr 2.41TCr 195.41Cr 191.23Cr 8.34TCr P/E 2026 *
-5.35x
P/E 2027 * -9.6x
Enterprise Value 61Cr 78Cr 67Cr 58Cr 108.73Cr 7.31TCr 109.64Cr 728.52Cr 283.63Cr 3.59TCr 290.9Cr 284.69Cr 12TCr EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.48x
Free-Float
66.94%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 52Cr
-0.90%-7.58%-16.63%-35.60% 1.44TCr
-1.79%-5.17%-29.94%-36.17% 693.2Cr
-0.06%-2.07%-17.27%-14.72% 574.39Cr
-2.08%-6.39%-19.23%-37.50% 354.86Cr
-0.33%-0.85%-34.84%-13.22% 337.37Cr
-1.24%+1.38%-22.36%-44.99% 334.94Cr
+0.36%+1.13%+121.37% - 274.81Cr
-3.13%-2.31%+0.75%-44.28% 270.81Cr
-0.49%-0.54%-15.59%-1.59% 257.68Cr
Average -0.97%-1.79%-3.75%-28.51% 504.69Cr
Weighted average by Cap. -1.03%-3.23%-11.27%-30.50%

Financials

2026 *2027 *
Net sales 121.74Cr 153.49Cr 132.41Cr 114.58Cr 215.31Cr 14TCr 217.12Cr 1.44TCr 561.67Cr 7.11TCr 576.07Cr 563.76Cr 25TCr 136.81Cr 172.48Cr 148.8Cr 128.77Cr 241.96Cr 16TCr 243.99Cr 1.62TCr 631.19Cr 7.99TCr 647.36Cr 633.53Cr 28TCr
Net income -8.42Cr -11Cr -9.16Cr -7.92Cr -15Cr -1TCr -15Cr -100Cr -39Cr -491.54Cr -40Cr -39Cr -1.7TCr -4.83Cr -6.09Cr -5.25Cr -4.54Cr -8.54Cr -574.54Cr -8.61Cr -57Cr -22Cr -281.98Cr -23Cr -22Cr -975.48Cr
Net Debt 20Cr 25Cr 22Cr 19Cr 36Cr 2.4TCr 36Cr 239.16Cr 93Cr 1.18TCr 95Cr 93Cr 4.08TCr 24Cr 30Cr 26Cr 23Cr 43Cr 2.86TCr 43Cr 285.24Cr 111.05Cr 1.41TCr 113.9Cr 111.46Cr 4.86TCr
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
8.515CHF
Average target price
7.494CHF
Spread / Average Target
-11.99%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!